Integrative Health Grand Rounds: Revisiting psychedelics: what we know about psilocybin in the treatment of depression

Atheir Abbas, M.D., Ph.D., Assistant Professor of Behavioral Neuroscience, School of Medicine, OHSU; Assistant Professor of Psychiatry, School of Medicine, OHSU

When	September 15, 2022 12 p.m. to 1 p.m. Add to Calendar 2022-09-15 12:00:00 2022-09-15 13:00:00 Integrative Health Grand Rounds: Revisiting psychedelics: what we know about psilocybin in the treatment of depression Welcome to the first of many Integrative Health Grand Rounds hosted by OHSU Integrative Health Collaborative (OIHC). We are so happy you chose to join us! Learn more about OIHC and/or to make a donation to help us expand our offerings, please explore more of the website you're currently visiting. For patient-centered information, please visit www.ohsu.edu/primary-care/integrative-medicine. To join our mailing list and/or to join our efforts, please email us at oihc@ohsu.edu , About Atheir Abbas, M.D., Ph.D. It is our absolute pleasure to welcome our first speaker Dr. Atheir Abbas, Assistant Professor in the Department of Behavioral Neuroscience and the Department of Psychiatry at OHSU. He is a staff psychiatrist at the Portland VA Medical Center, where he practices as a Consultation-Liaison Psychiatrist. He completed his combined MD/PhD training at Case Western Reserve University under the mentorship of Dr. Bryan Roth, where he studied 5-HT2AR signaling, characterizing the role of the receptor's C-terminal tail in linking to glutaminergic signaling pathways. He then completed his Psychiatry residency and postdoctoral research training at Columbia University, where he trained under Dr. Josh Gordon. Since Spring 2022, Dr. Abbas has been Chair of the Oregon Psilocybin Advisory Board and has co-chaired its Research Subcommittee since 2021. His research laboratory combines multi-region in vivo electrophysiologic recordings obtained during awake, freely-moving cognitive behaviors such as working memory with optogenetics and computational analyses to study mechanisms of rhythmic coordination within prefrontal cortex-associated circuits. Contact: oihc@ohsu.edu OHSU Integrative Health Collaborative <p></p><p><a href="https://www.ohsu.edu/node/5712861">Integrative Health Grand Rounds: Revisiting psychedelics: what we know about psilocybin in the treatment of depression</a></p> oihc@ohsu.edu America/Los_Angeles public
Where	Webex Join Online: https://ohsu.webex.com/ohsu/j.php?MTID=me27a47626b1eacf1342ed0793690aba7 Meeting number: 2624 983 0935 Meeting Password: JRx8DN8RvW6 Join by phone: +1-503-388-9555 (Portland, OR Toll) Access Code: 26249830935 Join from a video or application: Dial 26249830935@ohsu.webex.com, or dial 173.243.2.68 and enter meeting number 2624 983 0935 Global call-in numbers: https://ohsu.webex.com/ohsu/globalcallin.php?MTID=m4a1a22c53b19cc39852e9b0730fe085d
Contact Information	oihc@ohsu.edu OHSU Integrative Health Collaborative

Welcome to the first of many Integrative Health Grand Rounds hosted by OHSU Integrative Health Collaborative (OIHC). We are so happy you chose to join us!

Learn more about OIHC and/or to make a donation to help us expand our offerings, please explore more of the website you're currently visiting.

For patient-centered information, please visit www.ohsu.edu/primary-care/integrative-medicine.

To join our mailing list and/or to join our efforts, please email us at oihc@ohsu.edu

About Atheir Abbas, M.D., Ph.D.

It is our absolute pleasure to welcome our first speaker Dr. Atheir Abbas, Assistant Professor in the Department of Behavioral Neuroscience and the Department of Psychiatry at OHSU. He is a staff psychiatrist at the Portland VA Medical Center, where he practices as a Consultation-Liaison Psychiatrist. He completed his combined MD/PhD training at Case Western Reserve University under the mentorship of Dr. Bryan Roth, where he studied 5-HT2AR signaling, characterizing the role of the receptor's C-terminal tail in linking to glutaminergic signaling pathways. He then completed his Psychiatry residency and postdoctoral research training at Columbia University, where he trained under Dr. Josh Gordon.

Since Spring 2022, Dr. Abbas has been Chair of the Oregon Psilocybin Advisory Board and has co-chaired its Research Subcommittee since 2021. His research laboratory combines multi-region in vivo electrophysiologic recordings obtained during awake, freely-moving cognitive behaviors such as working memory with optogenetics and computational analyses to study mechanisms of rhythmic coordination within prefrontal cortex-associated circuits.